These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20213820)

  • 21. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease.
    van Es AC; van der Flier WM; Admiraal-Behloul F; Olofsen H; Bollen EL; Middelkoop HA; Weverling-Rijnsburger AW; Westendorp RG; van Buchem MA
    Neurobiol Aging; 2006 Dec; 27(12):1757-62. PubMed ID: 16290268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional patterns of brain tissue loss associated with depression in Parkinson disease.
    Kostić VS; Agosta F; Petrović I; Galantucci S; Spica V; Jecmenica-Lukic M; Filippi M
    Neurology; 2010 Sep; 75(10):857-63. PubMed ID: 20686125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease.
    Lee SJ; Kim JS; Yoo JY; Song IU; Kim BS; Jung SL; Yang DW; Kim YI; Jeong DS; Lee KS
    Alzheimer Dis Assoc Disord; 2010; 24(3):227-33. PubMed ID: 20473133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profile of memory impairment and gray matter loss in amnestic mild cognitive impairment.
    Barbeau EJ; Ranjeva JP; Didic M; Confort-Gouny S; Felician O; Soulier E; Cozzone PJ; Ceccaldi M; Poncet M
    Neuropsychologia; 2008 Mar; 46(4):1009-19. PubMed ID: 18191160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2010 Apr; 25(5):615-22. PubMed ID: 20175186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Tolosa E; Marti MJ; Valldeoriola F; Bargallo N; Zarei M
    Eur J Neurosci; 2009 Sep; 30(6):1162-71. PubMed ID: 19735293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.
    Bozzali M; Filippi M; Magnani G; Cercignani M; Franceschi M; Schiatti E; Castiglioni S; Mossini R; Falautano M; Scotti G; Comi G; Falini A
    Neurology; 2006 Aug; 67(3):453-60. PubMed ID: 16894107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
    Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study.
    Antonova E; Kumari V; Morris R; Halari R; Anilkumar A; Mehrotra R; Sharma T
    Biol Psychiatry; 2005 Sep; 58(6):457-67. PubMed ID: 16039619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.